PodcastsPodcasts

The Clinical Utility of Guselkumab in CD

Simplifying Access: Prior Authorization Part 1

Simplifying Access: Prior Authorization Part 2

Simplifying Access: Evolving Drug Distribution Channels

GHAPPcast: The Clinical Utility of Guselkumab in UC

GHAPPcast Part 3: Provider & Patient Support

GHAPPcast Part 2: Diagnosis and Management

Biomarkers Beyond ALP to Monitor for Measuring PBC UDCA Response to Therapy and Disease Progression

GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis

GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications

GHAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of IBD

Importance of Understanding Impact on Disease Outcomes: Progression to Fibrosis and Cirrhosis

Building a Sense of Urgency for PBC Patient Evaluation/Monitoring

Need for Earlier Evaluation of UDCA Response, Need for Earlier Consideration of Second-Line Therapy

Not Responding to UDCA in the First Few Months, Need to Move on to Second-Line Therapy

Better Understanding of PBC Patients Overall Liver Health and Managing Patients Holistically

Unable to Differentiate/Identify Between Slow & Fast Progressors - Need to Manage More Aggressively

Need for Clinicians to Better Understand The "Area Under the Curve" in Non-Response to UDCA

GHAPPcast: CSID in Adults: Clinical Pearls & the Patient Journey

GHAPP PBC Podcast Series Part 3: The Key Highlights of PBC at the GHAPP Conference 2024

sectionimg

dotimg

Download the app and start using it now

Download on the App Store

GET IT ON Google Play